Diane Kowalski, M.D., Director
José Costa, M.D.

• General Information
• Areas of Expertise
• Frequently Asked Questions
• People

pleomorphic adenoma
 

Head and Neck Pathology Service
Department of Pathology
Yale School of Medicine
PO Box 208023
New Haven CT 06520-8023


General Information

The Yale Program of Head and Neck Pathology, directed by Diane Kowalski, M.D., specializes in all neoplastic and non-neoplastic diseases of the head and neck region. Biopsies as well as complete resections from the larynx, nasopharynx, paranasal sinuses, oral cavity, salivary gland, thyroid, and neck are examined with special emphasis on correlation with therapy and the use of predictive markers. Centered at Yale-New Haven Hospital, the service offers state-of-the-art diagnostic facilities, including molecular diagnostics, cytopathology, immunocytochemistry, electron microscopy, flow cytometry, and cytogenetics.

HIGHLIGHTS

• Statewide and national consultation service

• Extensive collaborative research activity with the sections of head and neck surgery, medical oncology, and radiation oncology

• Weekly interdisciplinary head and neck tumor board

• On-site head and neck FNA diagnosis by cytopathologists

• Microarray technology

Areas of Expertise

• Pathology of the larynx and hypopharynx

• Molecular biology of the head and neck

• Thyroid disease: extensive expertise in the diagnosis and management of patients with thyroid abnormalities

• Soft tissue and bone lesions

Frequently Asked Questions

Which molecular techniques can be applied to tumors of the head and neck region, and does the surgical pathologist play a role in this?

Surgical pathologists need to be aware of special procedures that ensure proper tissue preparation and storage for molecular analysis. Molecular techniques that can be applied to solid tumors of the head and neck include cytogenetics, PCR, FISH, and microarray analysis.

Why do patients with primary head and neck tumors often develop a second metachronous or synchronous tumor?

The subsequent tumors are thought to be due to ”field cancerization.” This suggests that a single migrating transformed cell gives rise to a clonal population of cells that are not yet fully transformed, but with time, will arise as new preinvasive or invasive lesions.

People  

Diane Kowalski, M.D., Director, is Assistant Professor of Pathology and Attending Pathologist, YNHH. She is Director of the Fine Needle Aspiration Clinic at Yale-New Haven Hospital. Her clinical interests include cytopathology and head and neck pathology.

José Costa, M.D., is Professor and Co-Vice Chair of Pathology, Director of Anatomic Pathology, Deputy Director of the Yale Comprehensive Cancer Center, Director of Yale Critical Technologies in Molecular Medicine, and Attending Pathologist, YNHH; Clinical interests: oncologic pathology and molecular diagnostics.


back to top || HOME